Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice

被引:29
|
作者
Veerman, K. J. [1 ]
Venegas-Pino, D. E. [2 ,3 ]
Shi, Y. [1 ]
Khan, M. I. [1 ]
Gerstein, H. C. [3 ,4 ,5 ]
Werstuck, G. H. [1 ,2 ,3 ]
机构
[1] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada
[2] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada
[3] McMaster Univ, Dept Med, Hamilton, ON, Canada
[4] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[5] Populat Hlth Res Inst, Hamilton, ON, Canada
关键词
Atherosclerosis; Hyperglycaemia; Vasa vasorum; Neovascularization; ENDOTHELIAL GROWTH-FACTOR; DIABETES-MELLITUS; TGF-BETA; HYPOXIA; ANGIOGENESIS; MORTALITY; DISEASE; PROGRESSION; RETINOPATHY; EXPRESSION;
D O I
10.1016/j.atherosclerosis.2013.01.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: A direct correlation between blood glucose levels and the microvascular complications of diabetes is well established. However, the effects of hyperglycaemia on the vasa vasorum, a microvascular network which surrounds and supplies the walls of large arteries, is not known. The objective of this study is to investigate the effects of hyperglycaemia on the vasa vasorum and to examine correlations between these effects and the development of atherosclerosis in a mouse model. Methods: The micro- and macrovascular effects of hyperglycaemia were examined in streptozotocin-injected apolipoprotein-E deficient (ApoE(-/-))mice. Retina and aortic sinus were isolated from hyperglycaemic mice and normoglycaemic controls at 5-20 weeks of age. Retinal and vasa vasorum microvessel densities were quantified and correlated to atherosclerotic lesion development. The expression levels of pro-angiogenic factors including vascular endothelial growth factor (VEGF) and VEGF receptor 2 were examined. Results: In normoglycaemic ApoE(-/-) mice atherogenesis is associated with vasa vasorum expansion, which likely corresponds to the increasing blood supply demands of the thickening artery wall. In hyperglycaemic ApoE(-/-) mice there is no significant neovascularization of the vasa vasorum, despite the fact that lesions are significantly larger. This defect may result from a localized deficiency in VEGF. Conclusions: These findings are the first evidence that hyperglycaemia alters the structure of the vasa vasorum. Such microvascular changes directly correlate, and may contribute to, the development and progression of atherosclerosis in hyperglycaemic ApoE-deficient mice. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:250 / 258
页数:9
相关论文
共 50 条
  • [1] Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice
    Ma, Lianyue
    Ni, Mei
    Hao, Panpan
    Lu, Huixia
    Yang, Xiaoyan
    Xu, Xingli
    Zhang, Cheng
    Huang, Shanying
    Zhao, Yuxia
    Liu, Xiaoling
    Zhang, Yun
    ONCOTARGET, 2016, 7 (13) : 16194 - 16204
  • [2] Plaque-Associated Vasa Vasorum in Aged Apolipoprotein E-Deficient Mice Exhibit Proatherogenic Functional Features In Vivo
    Rademakers, Timo
    Douma, Kim
    Hackeng, Tilman M.
    Post, Mark J.
    Sluimer, Judith C.
    Daemen, Mat J. A. P.
    Biessen, Erik A. L.
    Heeneman, Sylvia
    van Zandvoort, Marc A. M. J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (02) : 249 - +
  • [3] Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity
    Schreyer, SA
    Lystig, TC
    Vick, CM
    LeBoeuf, RC
    ATHEROSCLEROSIS, 2003, 171 (01) : 49 - 55
  • [4] Pioglitazone suppresses macrophage proliferation in apolipoprotein-E deficient mice by activating PPARγ
    Murakami-Nishida, Saiko
    Matsumura, Takeshi
    Senokuchi, Takafumi
    Ishii, Norio
    Kinoshita, Hiroyuki
    Yamada, Sarie
    Morita, Yutaro
    Nishida, Shuhei
    Motoshima, Hiroyuki
    Kondo, Tatsuya
    Komohara, Yoshihiro
    Araki, Eiichi
    ATHEROSCLEROSIS, 2019, 286 : 30 - 39
  • [5] The effect of tocopheryl phosphates (TPM) on the development of atherosclerosis in apolipoprotein-E deficient mice
    Libinaki, Roksan
    Vinh, Antony
    Tesanovic-Klajic, Sonja
    Widdop, Robert
    Gaspari, Tracey
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 : 107 - 116
  • [6] Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice
    Pedersen, Tanja X.
    Bro, Susanne
    Andersen, Mikkel H.
    Etzerodt, Michael
    Jauhiainen, Matti
    Moestrup, Soren
    Nielsen, Lars B.
    ATHEROSCLEROSIS, 2009, 202 (02) : 372 - 381
  • [7] Efficacy of Terpenoid in Attenuating Aortic Atherosclerosis in Apolipoprotein-E Deficient Mice: A Meta-Analysis of Animal Studies
    Liu, Han
    Zhang, Yang
    Sun, Siqiao
    Wang, Shuai
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [8] Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E
    JD Harris
    S Schepelmann
    T Athanasopoulos
    IR Graham
    AK Stannard
    Z Mohri
    V Hill
    DG Hassall
    JS Owen
    G Dickson
    Gene Therapy, 2002, 9 : 21 - 29
  • [9] Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E
    Harris, JD
    Schepelmann, S
    Athanasopoulos, T
    Graham, IR
    Stannard, AK
    Mohri, Z
    Hill, V
    Hassall, DG
    Owen, JS
    Dickson, G
    GENE THERAPY, 2002, 9 (01) : 21 - 29
  • [10] Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice
    Posthuma, Jelle J.
    Posma, Jens J. N.
    van Oerle, Rene
    Leenders, Peter
    van Gorp, Rick H.
    Jaminon, Armand M. G.
    Mackman, Nigel
    Heitmeier, Stefan
    Schurgers, Leon J.
    ten Cate, Hugo
    Spronk, Henri M. H.
    SCIENTIFIC REPORTS, 2019, 9 (1)